Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Guy

Sports Medicine Columbia, SC Medical Doctor

NPI 1447214408 CMS profile 65580

14 Richland Medical Park Dr Ste 200, Columbia, SC 29203

Open in the dashboard

General payments

$120,291

275 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeffrey Guy of Columbia, SC is reported in the CMS Open Payments database as having received $120,291 across 275 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $54,044 44
2024 General $10,601 29
2023 General $19,716 41
2022 General $13,753 47
2021 General $12,765 42
2020 General $5,067 34
2019 General $4,344 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Guy
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Jeffrey Guy were reported at $54,044. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Jeffrey Guy Sports Medicine median Middle half National median
2019 $4,344 $1,176 $199–$4,249 $163
2020 $5,067 $708 $96–$2,890 $114
2021 $12,765 $1,213 $152–$3,994 $132
2022 $13,753 $1,230 $159–$3,998 $149
2023 $19,716 $584 $146–$2,836 $160
2024 $10,601 $628 $163–$3,168 $164
2025 $54,044 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $103,203 178 payments
  2. Peerless Surgical Inc. $13,700 62 payments
  3. Djo, LLC $1,147 9 payments
  4. Smith+Nephew, Inc. $885 11 payments
  5. Flexion Therapeutics, Inc. $312 4 payments
  6. Stryker Corporation $218 2 payments
  7. Anika Therapeutics, Inc. $201 2 payments
  8. Abanza Inc. $154 1 payment
  9. Organogenesis Inc. $148 1 payment
  10. Smoky Mountain Surgical LLC $122 1 payment
  11. Other $200 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $80,846 10 payments
  2. Travel and Lodging $20,393 72 payments
  3. Food and Beverage $8,611 188 payments
  4. Consulting Fee $6,300 1 payment
  5. Education $4,140 4 payments
Products named General payments · program years 2019–2025
  1. DONJOY $388 3 payments
  2. AIRCAST $388 3 payments
  3. Zilretta $312 4 payments
  4. ACCULIF $218 2 payments
  5. PROCARE $209 2 payments
  6. WasherCap Fixation System 10mm $154 1 payment
  7. Kischner wire $154 1 payment
  8. CAP-FIX $148 1 payment
  9. Puraply, NuShield, Affinity $148 1 payment
  10. Bioinductive Implant with Arthroscopic Delivery System - Medium $144 2 payments
  11. Other $1,512 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

75

Median for Orthopedic Surgery: 203

Drug cost

$1,249

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Naloxone Hcl Generic 15 $955
Ibuprofen Generic 21 $126
Oxycodone Hcl Generic 26 $85
Naproxen Generic 13 $83

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$52,069

Of which drugs: $2,887

Medicare patients

172

Average age 69

Services billed

2,071

96 women, 76 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Ischemic heart disease 26%
Diabetes 23%
Depression 20%
Atrial fibrillation 15%
Cancer 15%
Chronic kidney disease 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 18 1,560 $157

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

275 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record